PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11098498-9	2000	Dorsal air sac assay revealed that UFT, 5-FU, and gamma-hydroxybutyric acid strongly inhibited the angiogenesis induced by recombinant human VEGF.	Tegafur	35-38	vascular endothelial growth factor A	Homo sapiens	141-145	
23739924-2	2014	Gamma-butyrolactone (GBL) is a metabolite of tegafur that is known to suppress vascular endothelial growth factor (VEGF)-mediated angiogenic activity.	Tegafur	45-52	vascular endothelial growth factor A	Homo sapiens	79-113	
23739924-2	2014	Gamma-butyrolactone (GBL) is a metabolite of tegafur that is known to suppress vascular endothelial growth factor (VEGF)-mediated angiogenic activity.	Tegafur	45-52	vascular endothelial growth factor A	Homo sapiens	115-119	
11911014-3	2001	Here we report that UFT was more effective than other fluorinated pyrimidines such as 5-FU and doxifluridine (5"-DFUR) in blocking the angiogenic responses elicited by five human cancer cell lines which produced high levels of vascular endothelial growth factor (VEGF), but no detectable fibroblast growth factor-2 (FGF-2) in vitro.	Tegafur	20-23	vascular endothelial growth factor A	Homo sapiens	227-261	
11911014-3	2001	Here we report that UFT was more effective than other fluorinated pyrimidines such as 5-FU and doxifluridine (5"-DFUR) in blocking the angiogenic responses elicited by five human cancer cell lines which produced high levels of vascular endothelial growth factor (VEGF), but no detectable fibroblast growth factor-2 (FGF-2) in vitro.	Tegafur	20-23	vascular endothelial growth factor A	Homo sapiens	263-267